Phenotypic, genotypic, cytochemical, and ultrastructural characterization of acute undifferentiated leukemia.
During the diagnostic investigation of 750 acute leukemias, nine cases were morphologically, cytochemically, and phenotypically undifferentiated. In seven of these cases the blasts were class II+, CD34+ and TdT+, in one were class II+, TdT+, CD7+ while in the remaining leukemia blasts expressed class II only. Cytoplasmic and membrane CD22, CD3, CD13, and Ig as well as membrane CD19, CD10, CD37, CD2, CD33, CD14, glycophorin C, and CD61 were absent. The further characterization of these rare leukemias yielded the following results. The TCR-beta, -gamma and -delta genes were in germline configuration in seven cases studied while IgH genes were rearranged on both alleles in two cases and germline in the other five. By ultrastructural analysis peroxidase activity was detected on unfixed cells in a minority of blasts from four of seven cases. In two of the peroxidase-positive cases a small proportion of blasts also reacted with an anti-myeloperoxidase monoclonal antibody. In one of the peroxidase-negative cases, 7% of blasts were labeled by the antibody, suggesting the presence of peroxidase in its proenzyme form. Importantly, the two cases with Ig gene rearrangements did not have cytochemically or immunologically detectable peroxidase. Three of the nine patients were treated as ALL while six received AML chemotherapy. In five patients complete remission was achieved while the other four died from infections during remission induction. Four patients are still in remission 7, 12, 24, and 30 months after diagnosis while one patient relapsed after 12 months. In conclusion, we have characterized the genotypic and ultrastructural features of subtype of acute leukemia in which blasts expressed immaturity markers and lacked lineage associated antigens. In contrast to previously reported "unclassifiable" cases, the leukemias were phenotypically homogeneous and showed a good response to chemotherapy.
Campana
D
D
Department of Immunology, Royal Free Hospital School of Medicine, London, U.K.
Hansen-Hagge
T E
TE
Matutes
E
E
Coustan-Smith
E
E
Yokota
S
S
Shetty
V
V
Bartram
C R
CR
Janossy
G
G
D000208:Acute Disease; D000293:Adolescent; D000368:Aged; D000943:Antigens, Differentiation / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004792:Enzyme Precursors / Q000032:analysis; D005260:Female; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain; D015329:Gene Rearrangement, T-Lymphocyte; D005838:Genotype; D006801:Humans; D007150:Immunohistochemistry; D007938:Leukemia / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D010544:Peroxidases / Q000032:analysis; D010641:Phenotype; D012074:Remission Induction
D000943:Antigens, Differentiation; D004792:Enzyme Precursors; D010544:Peroxidases